Bone morphogenetic protein 2 facilitates the apoptosis of smooth muscle cells of intracranial aneurysms in rats through up-regulation of Smad1/5 phosphorylation

左乔,唐海双,张小曦,薛盖茨,赵瑞,李强,方亦斌,杨鹏飞,黄清海,刘建民
DOI: https://doi.org/10.3760/cma.j.cn112050-20191216-00524
2020-01-01
Abstract:Objective:To investigate the role of bone morphogenetic protein 2(BMP2) signaling pathway in the development of intracranial aneurysms and its mechanism in regulating the apoptosis of vascular smooth muscle cells (VSMCs).Methods:The healthy male SD rats were divided into 2 groups according to the random number table method, which were the model group ( n=32) and the sham operation group ( n=32). In the model group, the intracranial aneurysm model was established by ligating the left external carotid artery, the left pterygopalatine artery and the right common carotid artery of the rat. The vessels were not ligated in sham operation group. The rats in both groups were sacrificed at 3 months after operation, and the model establishment was judged by electron microscopy observation and hematoxylin-eosin (HE) staining. BMP2 and downstream phosphorylated Smad1/5(p-Smad 1/5) expression in VSMCs of the rats′ anterior communicating artery complex in both groups were detected by immunohistochemical staining and Western blotting respectively. VSMCs of the rat′s cerebral arteries were further cultured in vitro and divided into 3 groups: control group, BMP2 group(add BMP2 100 ng/ml) and Smad6+ BMP2 group(trasfect Smad6 overexpression vector+ add BMP2 100 ng/ml). The apoptosis of VSMCs in each group was detected by TUNEL (terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling), and the expression of Caspase3, BMP2 and downstream phosphorylated Smad1/5 of VSMCs in each group was detected by Western blotting. Results:Compared with the sham group, the rat′s cerebral arteries had different degrees of lesions in the model group, and VSMCs of the blood vessel wall had obvious remodeling and apoptosis by electron microscopy observation and HE staining, indicating that the disease model was established successfully. The immunohistochemical staining showed that the relative expression levels of Caspase3 (0.25 ± 0.03 vs. 0.06 ± 0.01) and BMP2 (0.12 ± 0.03 vs. 0.06 ± 0.01) were increased significantly in the model group compared with the sham group (both P < 0.05). Compared with the sham group, the Western blotting results showed that BMP2 (0.50 ± 0.04 vs. 0.75 ± 0.07) and p-Smad1/5 (0.27±0.04 vs. 0.73±0.07) relative expression in the model group was increased significantly (both P < 0.05). The TUNEL detection showed that the apoptosis rates of VSMCs in BMP2 group (4.35% ± 0.65% vs. 74.63% ± 6.05%) and Smad6+ BMP2 group (4.35% ± 0.65% vs. 45.92% ± 1.08%) were significantly increased compared with those in the control group (both P <0.01), while the VSMCs apoptosis rate in the Smad6 + BMP2 group was less than that in the BMP2 group ( P < 0.01). Western blotting results showed that the relative expression levels of p-Smad1/5 and Caspase3 in the BMP2 group and Smad6 + BMP2 group were both increased compared with those in the control group (both P < 0.01), while the expression levels of p-Smad1/5 and Caspase3 in the Smad6 + BMP2 group were lower than those in the BMP2 group(both P <0.05). Conclusions:BMP2 and downstream p-Smad1/5 are closely related to the apoptosis of VSMCs in intracranial aneurysms. The apoptosis of VSMCs mediated by BMP/Smad signaling pathway may be one of the mechanisms of the occurrence and development of intracranial aneurysms.
What problem does this paper attempt to address?